Selected research
Industry Growth & Trends
Global Continuous Glucose Monitor (CGM) Solution Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Continuous Glucose Monitor (CGM) Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Continuous Glucose Monitor (CGM) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Continuous Glucose Monitor (CGM) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Continuous Glucose Monitor (CGM) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Continuous Glucose Monitor (CGM) Solution market include Roche, Nutrisense, Levels Health, Eversense, Abbott, Dexcom, Medtronic, Changsha Sinocare and Beijing Yicheng Bioelectronics Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Continuous Glucose Monitor (CGM) Solution market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Continuous Glucose Monitor (CGM) Solution market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Continuous Glucose Monitor (CGM) Solution market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Continuous Glucose Monitor (CGM) Solution.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Continuous Glucose Monitor (CGM) Solution market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Continuous Glucose Monitor (CGM) Solution Market by Company
Roche
Nutrisense
Levels Health
Eversense
Abbott
Dexcom
Medtronic
Changsha Sinocare
Beijing Yicheng Bioelectronics Technology
Ottai Technology (Wuxi)
Hangzhou MicroTech Medical
Continuous Glucose Monitor (CGM) Solution Segment by Type
Hardware
Software
Continuous Glucose Monitor (CGM) Solution Segment by Application
Clinical Treatment
Sports & Fitness
Others
Continuous Glucose Monitor (CGM) Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Continuous Glucose Monitor (CGM) Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Continuous Glucose Monitor (CGM) Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Continuous Glucose Monitor (CGM) Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Continuous Glucose Monitor (CGM) Solution companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Hardware
- Software
Applications
- Clinical Treatment
- Sports & Fitness
- Others
Companies covered
- Roche
- Nutrisense
- Levels Health
- Eversense
- Abbott
- Dexcom
- Medtronic
- Changsha Sinocare
- Beijing Yicheng Bioelectronics Technology
- Ottai Technology (Wuxi)
- Hangzhou MicroTech Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Continuous Glucose Monitor (CGM) Solution Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Continuous Glucose Monitor (CGM) Solution Market Size by Region (2021-2032)
- 1.4.1 Global Continuous Glucose Monitor (CGM) Solution Market Size by Region (2021-2026)
- 1.4.2 Global Continuous Glucose Monitor (CGM) Solution Market Size by Region (2027-2032)
- 1.5 Key Regions Continuous Glucose Monitor (CGM) Solution Market Size (2021-2032)
- 1.5.1 North America Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate (2021-2032)
- 1.5.4 South America Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate (2021-2032)
2 Continuous Glucose Monitor (CGM) Solution Market by Type
- 2.1 Type Introduction
- 2.1.1 Hardware
- 2.1.2 Software
- 2.2 Global Continuous Glucose Monitor (CGM) Solution Market Size by Type
- 2.2.1 Global Continuous Glucose Monitor (CGM) Solution Market Size Overview by Type (2021-2032)
- 2.2.2 Global Continuous Glucose Monitor (CGM) Solution Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Continuous Glucose Monitor (CGM) Solution Market Size Forecasted by Type (2027-2032)
- 2.3 Global Continuous Glucose Monitor (CGM) Solution Market Size by Regions
- 2.3.1 North America Continuous Glucose Monitor (CGM) Solution Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Continuous Glucose Monitor (CGM) Solution Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Continuous Glucose Monitor (CGM) Solution Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Continuous Glucose Monitor (CGM) Solution Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Continuous Glucose Monitor (CGM) Solution Market Size Breakdown by Type (2021-2026)
3 Continuous Glucose Monitor (CGM) Solution Market by Application
- 3.1 Type Introduction
- 3.1.1 Clinical Treatment
- 3.1.2 Sports & Fitness
- 3.1.3 Others
- 3.2 Global Continuous Glucose Monitor (CGM) Solution Market Size by Application
- 3.2.1 Global Continuous Glucose Monitor (CGM) Solution Market Size Overview by Application (2021-2032)
- 3.2.2 Global Continuous Glucose Monitor (CGM) Solution Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Continuous Glucose Monitor (CGM) Solution Market Size Forecasted by Application (2027-2032)
- 3.3 Global Continuous Glucose Monitor (CGM) Solution Market Size by Regions
- 3.3.1 North America Continuous Glucose Monitor (CGM) Solution Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Continuous Glucose Monitor (CGM) Solution Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Continuous Glucose Monitor (CGM) Solution Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Continuous Glucose Monitor (CGM) Solution Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Continuous Glucose Monitor (CGM) Solution Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Continuous Glucose Monitor (CGM) Solution Industry Trends
- 4.2 Continuous Glucose Monitor (CGM) Solution Industry Drivers
- 4.3 Continuous Glucose Monitor (CGM) Solution Industry Opportunities and Challenges
- 4.4 Continuous Glucose Monitor (CGM) Solution Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Continuous Glucose Monitor (CGM) Solution Revenue (2021-2026)
- 5.2 Global Continuous Glucose Monitor (CGM) Solution Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Continuous Glucose Monitor (CGM) Solution Key Company Headquarters & Area Served
- 5.4 Global Continuous Glucose Monitor (CGM) Solution Company, Product Type & Application
- 5.5 Global Continuous Glucose Monitor (CGM) Solution Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Continuous Glucose Monitor (CGM) Solution Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Continuous Glucose Monitor (CGM) Solution Players Market Share by Revenue in 2025
- 5.6.3 2025 Continuous Glucose Monitor (CGM) Solution Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Roche
- 6.1.1 Roche Company Information
- 6.1.2 Roche Business Overview
- 6.1.3 Roche Continuous Glucose Monitor (CGM) Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Roche Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.1.5 Roche Recent Developments
- 6.2 Nutrisense
- 6.2.1 Nutrisense Company Information
- 6.2.2 Nutrisense Business Overview
- 6.2.3 Nutrisense Continuous Glucose Monitor (CGM) Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Nutrisense Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.2.5 Nutrisense Recent Developments
- 6.3 Levels Health
- 6.3.1 Levels Health Company Information
- 6.3.2 Levels Health Business Overview
- 6.3.3 Levels Health Continuous Glucose Monitor (CGM) Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Levels Health Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.3.5 Levels Health Recent Developments
- 6.4 Eversense
- 6.4.1 Eversense Company Information
- 6.4.2 Eversense Business Overview
- 6.4.3 Eversense Continuous Glucose Monitor (CGM) Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Eversense Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.4.5 Eversense Recent Developments
- 6.5 Abbott
- 6.5.1 Abbott Company Information
- 6.5.2 Abbott Business Overview
- 6.5.3 Abbott Continuous Glucose Monitor (CGM) Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Abbott Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.5.5 Abbott Recent Developments
- 6.6 Dexcom
- 6.6.1 Dexcom Company Information
- 6.6.2 Dexcom Business Overview
- 6.6.3 Dexcom Continuous Glucose Monitor (CGM) Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Dexcom Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.6.5 Dexcom Recent Developments
- 6.7 Medtronic
- 6.7.1 Medtronic Company Information
- 6.7.2 Medtronic Business Overview
- 6.7.3 Medtronic Continuous Glucose Monitor (CGM) Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Medtronic Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.7.5 Medtronic Recent Developments
- 6.8 Changsha Sinocare
- 6.8.1 Changsha Sinocare Company Information
- 6.8.2 Changsha Sinocare Business Overview
- 6.8.3 Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Changsha Sinocare Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.8.5 Changsha Sinocare Recent Developments
- 6.9 Beijing Yicheng Bioelectronics Technology
- 6.9.1 Beijing Yicheng Bioelectronics Technology Company Information
- 6.9.2 Beijing Yicheng Bioelectronics Technology Business Overview
- 6.9.3 Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Beijing Yicheng Bioelectronics Technology Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.9.5 Beijing Yicheng Bioelectronics Technology Recent Developments
- 6.10 Ottai Technology (Wuxi)
- 6.10.1 Ottai Technology (Wuxi) Company Information
- 6.10.2 Ottai Technology (Wuxi) Business Overview
- 6.10.3 Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Ottai Technology (Wuxi) Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.10.5 Ottai Technology (Wuxi) Recent Developments
- 6.11 Hangzhou MicroTech Medical
- 6.11.1 Hangzhou MicroTech Medical Company Information
- 6.11.2 Hangzhou MicroTech Medical Business Overview
- 6.11.3 Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Hangzhou MicroTech Medical Continuous Glucose Monitor (CGM) Solution Product Portfolio
- 6.11.5 Hangzhou MicroTech Medical Recent Developments
7 North America
- 7.1 North America Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 7.3 North America Continuous Glucose Monitor (CGM) Solution Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 8.3 Europe Continuous Glucose Monitor (CGM) Solution Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Continuous Glucose Monitor (CGM) Solution Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 10.3 South America Continuous Glucose Monitor (CGM) Solution Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Continuous Glucose Monitor (CGM) Solution Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst